Cart
sales@molnova.com
Lycorine
CAS No. 476-28-8
Lycorine ( Lycorine; Galanthidine; NSC-401360; NSC401360 )
Catalog No. M18593 CAS No. 476-28-8
Lycorine inhibitsprotein synthesis and may inhibitascorbic acidbiosynthesis, although studies on the latter are controversial and inconclusive.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 27 | In Stock |
|
| 25MG | 43 | In Stock |
|
| 50MG | 61 | In Stock |
|
| 100MG | 98 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLycorine
-
NoteResearch use only, not for human use.
-
Brief DescriptionLycorine inhibitsprotein synthesis and may inhibitascorbic acidbiosynthesis, although studies on the latter are controversial and inconclusive.
-
DescriptionLycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer. It is a natural alkaloid extracted from the Amaryllidaceae plant family
-
SynonymsLycorine; Galanthidine; NSC-401360; NSC401360
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number476-28-8
-
Formula Weight287.31
-
Molecular FormulaC16H17NO4
-
Purity98%
-
Solubility——
-
SMILESC1CN2Cc3cc4c(cc3[C@H]3[C@H]2C1=C[C@@H]([C@H]3O)O)OCO4
-
Chemical Name(1S,2S,3a1S,12bS)-2,3a1,4,5,7,12b-hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vrijsen R. Biol. Chem. 1986, 261 (2): 505–7.
molnova catalog
related products
-
ATP synthase inhibit...
ATP synthase inhibitor 1 is an inhibitor of the c subunit of the F1/FO-ATP synthase complex. It inhibits mitochondrial permeability transition pore (mPTP) opening and does not affect ATP levels.
-
Oligomycin A
Oligomycin A, created by Streptomyces, acts as a mitochondrial F0F1-ATPase inhibitor, with a Ki of 1 μM.
-
NDI-091143
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
